# Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

> **NCT04883177** · — · COMPLETED · sponsor: **Hepatopancreatobiliary Surgery Institute of Gansu Province** · enrollment: 1000 (actual)

## Conditions studied

- COVID-19
- Liver Disease
- Vaccine Reaction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04883177
- **Lead sponsor:** Hepatopancreatobiliary Surgery Institute of Gansu Province
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-11
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2023-04-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04883177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04883177, "Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04883177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*